Newsroom | 4013 results

AACHEN, Alemania--(BUSINESS WIRE)--Protembis, empresa privada emergente dedicada a dispositivos médicos cardiovasculares, ha anunciado hoy la creación de un Consejo Científico Asesor (SAB) que proporcionará asesoramiento objetivo y contribuirá a los planes estratégicos de la empresa. En concreto, el CCC aportará orientación estratégica científica y clínica, asesorará sobre y oportunidades emergentes y tendencias, y proporcionará asesoramiento experto sobre asuntos científicos y clínicos. El Con...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Trust Wallet has surpassed 200 million total downloads, marking a game-changing milestone in the industry....

PALO ALTO, Calif.--(BUSINESS WIRE)--TensorOpera AI and Samsung Electronics announced a pioneering collaboration, which was showcased at the Consumer Electronics Show (CES) 2025 in Las Vegas, demonstrating the immense potential of deploying multi-modal generative AI applications directly on mobile devices powered by Samsung Exynos processors. This milestone marks a significant step forward in redefining the role of mobile technology in advancing artificial intelligence. Bringing generative AI to...

NEW YORK--(BUSINESS WIRE)--Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention. Every 40 seconds, someone in the US suf...

SAN JOSE, Calif.--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today announced the successful closing of its Series B financing with new investors Shangbay Capital and two undisclosed multinational strategics joining founding investor Vensana Capital. The funding will accelerate the development of the Company’s advanced IVUS technology designed to enhance vascular ima...

AACHEN, Deutschland--(BUSINESS WIRE)--Protembis, ein aufstrebendes Privatunternehmen für kardiovaskuläre Medizinprodukte, gab heute die Gründung eines wissenschaftlichen Beirats (Scientific Advisory Board, kurz SAB) bekannt, der objektive Beratung und Beiträge zu den strategischen Plänen des Unternehmens leisten soll. Konkret wird der SAB übergreifende wissenschaftliche und klinische strategische Leitlinien entwickeln, über aufkommende Trends und Chancen beraten sowie bei wissenschaftlichen und...

AQUISGRANA, Germania--(BUSINESS WIRE)--Protembis, un'azienda privata emergente nel settore dei dispositivi medici cardiovascolari, ha annunciato oggi la creazione di un comitato consultivo scientifico (SAB) per fornire una consulenza obiettiva e contribuire ai piani strategici dell'azienda. Il SAB fornirà nello specifico una guida strategica scientifica e clinica globale, fornirà raccomandazioni sulle tendenze e sulle opportunità emergenti e consulenza specialistica su questioni scientifiche e...

AACHEN, Duitsland--(BUSINESS WIRE)--Protembis, een opkomend bedrijf in privéhanden gespecialiseerd in cardiovasculaire medische hulpmiddelen, kondigde vandaag de oprichting aan van een SAB (Scientific Advisory Board) om objectief advies te verstrekken en de strategische plannen van het bedrijf vooruit te helpen. Meer specifiek zal de SAB overkoepelende wetenschappelijke en klinische strategische begeleiding bieden, advies over opkomende trends en mogelijkheden, en raad van experts over wetensch...

AIX-LA-CHAPELLE, Allemagne--(BUSINESS WIRE)--Protembis, une société privée de dispositifs médicaux cardiovasculaires émergents, a annoncé aujourd’hui la création d’un conseil consultatif scientifique (CCS) chargé de fournir des conseils objectifs et de contribuer aux plans stratégiques de la société. Plus précisément, le CCS fournira des orientations stratégiques scientifiques et cliniques globales, des conseils sur les tendances et les opportunités émergentes et des avis d’experts sur les ques...

SAN FRANCISCO--(BUSINESS WIRE)--The GTM10 Awards, powered by Cello and Lightspeed Venture Partners, is the world’s first annual program dedicated to recognizing the top Go-To-Market (GTM) operators across Customer Success, Growth, Marketing, Sales, and Partnerships in the Software industry. For too long, startup success has been measured by products and funding. But behind every high-growth software company are GTM leaders driving the strategies that turn vision into reality. The GTM10 Awards n...